Interestingly, knockdown of RPL19 by siRNA avoids prostatic malignancy in vitro and in vivo in PC-3M PCa cell lines suggesting that RPL19 could be used as a prognostic marker [56,57]. The gene discussed is RPL19; the disease is posterior cortical atrophy.